![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MED19 |
Gene summary for MED19 |
![]() |
Gene information | Species | Human | Gene symbol | MED19 | Gene ID | 219541 |
Gene name | mediator complex subunit 19 | |
Gene Alias | DT2P1G7 | |
Cytomap | 11q12.1 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | A0JLT2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
219541 | MED19 | LZE2T | Human | Esophagus | ESCC | 1.28e-02 | 3.74e-01 | 0.082 |
219541 | MED19 | LZE4T | Human | Esophagus | ESCC | 2.11e-16 | 3.82e-01 | 0.0811 |
219541 | MED19 | LZE5T | Human | Esophagus | ESCC | 3.33e-05 | 1.67e-01 | 0.0514 |
219541 | MED19 | LZE7T | Human | Esophagus | ESCC | 6.04e-13 | 4.78e-01 | 0.0667 |
219541 | MED19 | LZE8T | Human | Esophagus | ESCC | 1.43e-11 | 1.45e-01 | 0.067 |
219541 | MED19 | LZE20T | Human | Esophagus | ESCC | 8.84e-08 | 1.51e-01 | 0.0662 |
219541 | MED19 | LZE24T | Human | Esophagus | ESCC | 7.70e-22 | 5.96e-01 | 0.0596 |
219541 | MED19 | LZE6T | Human | Esophagus | ESCC | 9.32e-05 | 3.10e-01 | 0.0845 |
219541 | MED19 | P1T-E | Human | Esophagus | ESCC | 1.49e-10 | 6.22e-01 | 0.0875 |
219541 | MED19 | P2T-E | Human | Esophagus | ESCC | 2.91e-34 | 6.62e-01 | 0.1177 |
219541 | MED19 | P4T-E | Human | Esophagus | ESCC | 2.28e-62 | 1.35e+00 | 0.1323 |
219541 | MED19 | P5T-E | Human | Esophagus | ESCC | 2.17e-27 | 4.21e-01 | 0.1327 |
219541 | MED19 | P8T-E | Human | Esophagus | ESCC | 1.86e-41 | 7.89e-01 | 0.0889 |
219541 | MED19 | P9T-E | Human | Esophagus | ESCC | 2.10e-25 | 5.15e-01 | 0.1131 |
219541 | MED19 | P10T-E | Human | Esophagus | ESCC | 6.67e-25 | 5.66e-01 | 0.116 |
219541 | MED19 | P11T-E | Human | Esophagus | ESCC | 2.95e-22 | 8.85e-01 | 0.1426 |
219541 | MED19 | P12T-E | Human | Esophagus | ESCC | 1.32e-56 | 1.07e+00 | 0.1122 |
219541 | MED19 | P15T-E | Human | Esophagus | ESCC | 4.13e-22 | 3.40e-01 | 0.1149 |
219541 | MED19 | P16T-E | Human | Esophagus | ESCC | 1.73e-23 | 4.31e-01 | 0.1153 |
219541 | MED19 | P17T-E | Human | Esophagus | ESCC | 2.02e-13 | 6.40e-01 | 0.1278 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Liver | Cyst | ![]() |
Lung | IAC | ![]() |
Lung | AIS | ![]() |
Lung | AAH | ![]() |
Lung | MIAC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MED19 | insertion | Frame_Shift_Ins | novel | c.503dupG | p.Phe169LeufsTer25 | p.F169Lfs*25 | protein_coding | TCGA-E9-A227-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR | |||
MED19 | SNV | Missense_Mutation | novel | c.346A>G | p.Lys116Glu | p.K116E | protein_coding | deleterious(0.04) | probably_damaging(0.999) | TCGA-EA-A410-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
MED19 | SNV | Missense_Mutation | novel | c.599N>T | p.Arg200Leu | p.R200L | protein_coding | deleterious(0.03) | probably_damaging(0.983) | TCGA-AG-A014-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
MED19 | SNV | Missense_Mutation | c.530N>A | p.Pro177Gln | p.P177Q | protein_coding | deleterious(0.01) | probably_damaging(0.911) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
MED19 | SNV | Missense_Mutation | novel | c.682N>T | p.Arg228Trp | p.R228W | protein_coding | deleterious(0) | probably_damaging(0.975) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MED19 | SNV | Missense_Mutation | novel | c.541N>T | p.Arg181Cys | p.R181C | protein_coding | deleterious(0) | probably_damaging(0.961) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
MED19 | SNV | Missense_Mutation | c.529N>T | p.Pro177Ser | p.P177S | protein_coding | deleterious(0.02) | benign(0.3) | TCGA-AP-A1E0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | SD | ||
MED19 | SNV | Missense_Mutation | novel | c.339N>A | p.Phe113Leu | p.F113L | protein_coding | deleterious(0.04) | possibly_damaging(0.833) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD | |
MED19 | SNV | Missense_Mutation | novel | c.726N>G | p.His242Gln | p.H242Q | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.991) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
MED19 | SNV | Missense_Mutation | rs773968041 | c.434N>A | p.Arg145His | p.R145H | protein_coding | deleterious(0) | possibly_damaging(0.479) | TCGA-EY-A1G8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
219541 | MED19 | TRANSCRIPTION FACTOR BINDING, TRANSCRIPTION FACTOR | ethanol | ALCOHOL | 32451486 |
Page: 1 |